Cargando…

Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines

BACKGROUND: Cutaneous melanoma is an aggressive malignancy; its incidence is increasing worldwide and its prognosis remains poor. Clinical observations indicate that estrogen receptor β (ERβ) is expressed in melanoma tissues and its expression decreases with tumor progression, suggesting its tumor s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marzagalli, Monica, Casati, Lavinia, Moretti, Roberta M., Montagnani Marelli, Marina, Limonta, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520550/ https://www.ncbi.nlm.nih.gov/pubmed/26225426 http://dx.doi.org/10.1371/journal.pone.0134396

Ejemplares similares

Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
por: Marzagalli, Monica, et al.
Publicado: (2016)

Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells
por: Montagnani Marelli, Marina, et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner
por: Moretti, Roberta M., et al.
Publicado: (2014)

Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds
por: Limonta, Patrizia, et al.
Publicado: (2019)

Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
por: Fontana, Fabrizio, et al.
Publicado: (2020)

Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol
por: Marzagalli, Monica, et al.
Publicado: (2018)

δ‐Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells
por: Fontana, Fabrizio, et al.
Publicado: (2019)

Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
por: Cristofani, Riccardo, et al.
Publicado: (2018)

Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression
por: Anselmi, Martina, et al.
Publicado: (2022)

Ca(2+) overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
por: Raimondi, Michela, et al.
Publicado: (2021)

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy
por: Cristofani, Riccardo, et al.
Publicado: (2022)

Cancer Stem Cells—Key Players in Tumor Relapse
por: Marzagalli, Monica, et al.
Publicado: (2021)

Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
por: Montagnani Marelli, Marina, et al.
Publicado: (2023)

In Vitro 3D Cultures to Model the Tumor Microenvironment
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
por: Fontana, Fabrizio, et al.
Publicado: (2020)

Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
por: Fontana, Fabrizio, et al.
Publicado: (2019)

Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
por: Fontana, Fabrizio, et al.
Publicado: (2020)

δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Protein kinase C epsilon activation regulates proliferation, migration, and epithelial to mesenchymal-like transition in rat Schwann cells
por: Mohamed, Tasnim, et al.
Publicado: (2023)

Beneficial effects of δ-tocotrienol against oxidative stress in osteoblastic cells: studies on the mechanisms of action
por: Casati, Lavinia, et al.
Publicado: (2019)

Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro
por: Schüler-Toprak, Susanne, et al.
Publicado: (2016)

Apoptosis-mediated anticancer activity in prostate cancer cells of a chestnut honey (Castanea sativa L.) quinoline–pyrrolidine gamma-lactam alkaloid
por: Beretta, Giangiacomo, et al.
Publicado: (2021)

The Leaf Essential Oil of Myrtus communis subsp. tarentina (L.) Nyman: From Phytochemical Characterization to Cytotoxic and Antimigratory Activity in Human Prostate Cancer Cells
por: Giuliani, Claudia, et al.
Publicado: (2023)

Heterologous and cross-species tropism of cancer-derived extracellular vesicles
por: Garofalo, Mariangela, et al.
Publicado: (2019)

Antidiabetic Actions of an Estrogen Receptor β Selective Agonist
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2013)

The Role of HSPB8, a Component of the Chaperone-Assisted Selective Autophagy Machinery, in Cancer
por: Cristofani, Riccardo, et al.
Publicado: (2021)

Different Susceptibilities of Human Melanoma Cell Lines to G2/M Blockage and Cell Death Activation in Response to the Estrogen Receptor β agonist LY500307
por: Pontecorvi, Giada, et al.
Publicado: (2022)

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation
por: Maselli, Angela, et al.
Publicado: (2015)

The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?
por: Marzagalli, Rubina, et al.
Publicado: (2015)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
por: Singhal, Hari, et al.
Publicado: (2017)

Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2022)

Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)

Arctigenin functions as a selective agonist of estrogen receptor β to restrict mTORC1 activation and consequent Th17 differentiation
por: Wu, Xin, et al.
Publicado: (2016)

Endocrine disrupters: the new players able to affect the epigenome
por: Casati, Lavinia, et al.
Publicado: (2015)

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
por: Sareddy, Gangadhara R., et al.
Publicado: (2016)

Estrogen agonist genistein differentially influences the cognitive and motor disorders in an ovariectomized animal model of Parkinsonism
por: Arbabi, Elaheh, et al.
Publicado: (2016)

Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α
por: Rossini, Elisa, et al.
Publicado: (2021)

The unexpected science of estrogen receptor-β selective agonists: a new class of anti-inflammatory agents?
por: Harris, Heather A.
Publicado: (2006)

Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor β-Selective Agonists
por: Paruthiyil, Sreenivasan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_u9eejapu1j0ssv8b6lnqean7c5